Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesA Phase I Trial of Immunotherapy with Lapuleucel-T (APC8024) in Patients with Refractory Metastatic Tumors that Express HER-2/neu
Clinical Cancer Research, 09/15/09
Peethambaram PP et al. – Autologous active cellular immunotherapy with lapuleucel–T stimulated an immune response specific to the immunizing antigen and seemed to be well tolerated. Further clinical studies to assess the clinical benefit for patients with HER/2–neu–expressing breast, ovarian, and colorectal cancer are warranted.
Today in Vaccine/Immunotherapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
New England Journal of Medicine, 12/04/09
A significant reduction in hepatitis B virus infection among the children of Shandong Province, China: the effect of 15 years of universal infant hepatitis B vaccination
International Journal of Infectious Diseases, 12/04/09
Slowing Progression Along the Allergic Disease Continuum: Quo Vadit Immunotherapy
Pediatric Asthma, Allergy & Immunology, 12/04/09
Article Search
Sponsor